Free Trial

Danaher (DHR) Stock Price, News & Analysis

Danaher logo
$239.69 +0.86 (+0.36%)
(As of 01:10 PM ET)

About Danaher Stock (NYSE:DHR)

Key Stats

Today's Range
$238.30
$241.61
50-Day Range
$229.50
$278.02
52-Week Range
$215.68
$281.70
Volume
1.93 million shs
Average Volume
2.76 million shs
Market Capitalization
$173.12 billion
P/E Ratio
45.74
Dividend Yield
0.45%
Price Target
$287.16
Consensus Rating
Moderate Buy

Company Overview

Danaher Corporation, founded in 1984 by brothers Stephen and Mitchell Rales, is a globally diversified conglomerate headquartered in Washington, D.C. The company has evolved into a major player across various industries, offering a wide range of products and services in the medical, industrial, and commercial sectors. Danaher's mission is to innovate and provide high-quality solutions that positively impact people's lives worldwide. Danaher's began in 1984 as a Massachusetts real estate investment trust called DMG, Inc. The company underwent several reorganizations and strategic acquisitions, culminating in its present-day structure and diverse product portfolio.

Danaher is involved in designing, manufacturing, and marketing a broad array of products and services. Its offerings span medical diagnostics equipment, life sciences and diagnostics tools, environmental solutions, water quality analysis systems, industrial automation tools, and other specialized instruments. Danaher's mission is to leverage its technological expertise and commitment to continuous improvement to develop innovative solutions that enhance human well-being and drive sustainable growth.

The company's diverse product portfolio includes cutting-edge medical diagnostic devices, scientific instruments used in research and healthcare settings, water quality monitoring systems, and automation equipment for industrial applications. Danaher caters to various markets, including healthcare, life sciences, diagnostics, environmental monitoring, and industrial automation. Its products and services find applications in research institutions, healthcare facilities, industrial manufacturers, and government organizations.

Danaher Corporation boasts a leadership team comprising highly accomplished individuals with diverse expertise, driving the company's success and strategic direction. At the helm is Steven M. Rales, the Co-Founder and Chairman, who played a pivotal role in establishing Danaher and has been instrumental in shaping its strategic vision. With his visionary approach, Rales has steered the company towards sustained growth and innovation. Rainer M. Blair holds the positions of President, Chief Executive Officer, and Director, leading Danaher's day-to-day operations and spearheading its growth strategies. Blair's dynamic leadership has been crucial in driving the company's expansion and ensuring its position as a market leader.

Danaher has displayed excellent financial performance in recent years, with consistent revenue growth and profitability. The company's financial stability and strategic acquisitions have contributed to its robust performance. Danaher's strong financials indicate its ability to generate revenue and profits, which has positively influenced investor sentiment and contributed to its favorable valuation.

Danaher's valuation metrics demonstrate positive investor sentiment and confidence in the company's future growth prospects. Its favorable price-to-earnings ratio and price-to-cash flow ratio reflect investor willingness to pay a premium for its earnings potential and cash generation capacity. Danaher's stock performance has been noteworthy, driven by its strong financials, strategic initiatives, and positive market sentiment.

Investors should closely monitor any recent news or events that may have impacted Danaher's share price, such as industry developments or major acquisitions. Danaher operates in diverse industries with various competitors. Its competitive advantages, including a broad product portfolio and emphasis on innovation, position it well within its industries.

Danaher has ample growth opportunities, including expansion into emerging markets, strategic acquisitions, and research and development investments. The company's strong focus on continuous improvement and customer-centric solutions will drive its pursuit of growth opportunities.

Danaher faces potential risks and challenges, including market fluctuations, regulatory changes, and economic uncertainties. However, its proactive risk management strategies mitigate potential impacts on the company's financial performance.

Danaher Stock Analysis - MarketRank™

See Top Rated MarketRank™ Stocks
99th Percentile Overall Score

DHR MarketRank™: 

Danaher scored higher than 99% of companies evaluated by MarketBeat, and ranked 1st out of 26 stocks in the multi-sector conglomerates sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Danaher has received a consensus rating of Moderate Buy. The company's average rating score is 2.74, and is based on 14 buy ratings, 5 hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    Danaher has been the subject of 11 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

  • Read more about Danaher's stock forecast and price target.
  • Earnings Growth

    Earnings for Danaher are expected to grow by 11.73% in the coming year, from $7.50 to $8.38 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Danaher is 45.75, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 127.02.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Danaher is 45.75, which means that it is trading at a more expensive P/E ratio than the Multi-Sector Conglomerates sector average P/E ratio of about 7.09.

  • Price to Earnings Growth Ratio

    Danaher has a PEG Ratio of 4.39. PEG Ratios above 1 indicate that a company could be overvalued.

  • Price to Book Value per Share Ratio

    Danaher has a P/B Ratio of 3.37. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

  • Read more about Danaher's valuation and earnings.
  • Percentage of Shares Shorted

    0.73% of the float of Danaher has been sold short.
  • Short Interest Ratio / Days to Cover

    Danaher has a short interest ratio ("days to cover") of 1.9, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Danaher has recently decreased by 3.07%, indicating that investor sentiment is improving.
  • Dividend Yield

    Danaher has a dividend yield of 0.45%, which is in the bottom 25% of all stocks that pay dividends.

  • Dividend Growth

    Danaher does not have a long track record of dividend growth.

  • Dividend Coverage

    The dividend payout ratio of Danaher is 20.61%. This payout ratio is at a healthy, sustainable level, below 75%.

  • Dividend Sustainability

    Based on earnings estimates, Danaher will have a dividend payout ratio of 12.89% next year. This indicates that Danaher will be able to sustain or increase its dividend.

  • Read more about Danaher's dividend.
  • Percentage of Shares Shorted

    0.73% of the float of Danaher has been sold short.
  • Short Interest Ratio / Days to Cover

    Danaher has a short interest ratio ("days to cover") of 1.9, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Danaher has recently decreased by 3.07%, indicating that investor sentiment is improving.
  • News Sentiment

    Danaher has a news sentiment score of 1.08. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.71 average news sentiment score of Multi-Sector Conglomerates companies.
  • News Coverage This Week

    MarketBeat has tracked 28 news articles for Danaher this week, compared to 14 articles on an average week.
  • Search Interest

    23 people have searched for DHR on MarketBeat in the last 30 days. This is an increase of 53% compared to the previous 30 days.
  • MarketBeat Follows

    18 people have added Danaher to their MarketBeat watchlist in the last 30 days. This is an increase of 100% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Danaher insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    11.10% of the stock of Danaher is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Percentage Held by Institutions

    79.05% of the stock of Danaher is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Danaher's insider trading history.
Receive DHR Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Danaher and its competitors with MarketBeat's FREE daily newsletter.

DHR Stock News Headlines

Zacks Research Forecasts Danaher's Q2 Earnings (NYSE:DHR)
Danaher to Present at Evercore ISI HealthCONx Conference
I've got news for you…
Today, I’m doing something I thought I’d never do… Especially since I’m not normally a “swing for the fences” type of trader. But I’ve been quietly testing a new type of trade for a while now… And the returns are too good not to share with you. Take a look… I can’t guarantee results or against losses, but if you want to discover how I’ll target the triple return before the end of the week
Danaher (NYSE:DHR) Rating Lowered to Hold at StockNews.com
See More Headlines

DHR Stock Analysis - Frequently Asked Questions

Danaher's stock was trading at $231.34 on January 1st, 2024. Since then, DHR shares have increased by 3.6% and is now trading at $239.71.
View the best growth stocks for 2024 here
.

Danaher Co. (NYSE:DHR) posted its quarterly earnings data on Tuesday, October, 22nd. The conglomerate reported $1.71 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.57 by $0.14. The firm's quarterly revenue was up 3.1% compared to the same quarter last year.
Read the conference call transcript
.

Danaher subsidiaries include Aldevron, Precision NanoSystems, Aquatic Informatics, Cytiva, GE Biopharma, Integrated DNA Technologies, IDBS Group, and others.

Danaher's top institutional shareholders include State Street Corp (3.80%), FMR LLC (3.27%), Wellington Management Group LLP (3.23%) and Geode Capital Management LLC (1.81%). Insiders that own company stock include Alan G Spoon, Rainer Blair, Joakim Weidemanis, Linda Filler, Daniel Raskas, Matthew Mcgrew, Brian W Ellis, Teri List, Walter G Lohr, Raymond C Stevens, Jennifer Honeycutt, Jose-Carlos Gutierrez-Ramos, Georgeann Couchara, Elias A Zerhouni, Angela S Lalor and Angela S Lalor.
View institutional ownership trends
.

Shares of DHR stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

Based on aggregate information from My MarketBeat watchlists, some other companies that Danaher investors own include NVIDIA (NVDA), Meta Platforms (META), Broadcom (AVGO), UnitedHealth Group (UNH), BlackRock (BLK), JPMorgan Chase & Co. (JPM) and Advanced Micro Devices (AMD).

Company Calendar

Ex-Dividend for 10/25 Dividend
9/27/2024
Last Earnings
10/22/2024
Dividend Payable
10/25/2024
Today
11/29/2024
Fiscal Year End
12/31/2024
Next Earnings (Estimated)
2/04/2025

Industry, Sector and Symbol

Industry
Process control instruments
Sub-Industry
Industrial Conglomerates
CUSIP
23585110
Employees
63,000
Year Founded
1984

Price Target and Rating

Average Stock Price Target
$287.16
High Stock Price Target
$315.00
Low Stock Price Target
$250.00
Potential Upside/Downside
+19.7%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.74
Research Coverage
19 Analysts

Profitability

Net Income
$4.76 billion
Pretax Margin
19.22%

Debt

Sales & Book Value

Annual Sales
$23.89 billion
Cash Flow
$10.64 per share
Book Value
$71.03 per share

Miscellaneous

Free Float
642,102,000
Market Cap
$173.25 billion
Optionable
Optionable
Beta
0.85

Social Links

The 10 Best AI Stocks to Own in 2024 Cover

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report

This page (NYSE:DHR) was last updated on 11/29/2024 by MarketBeat.com Staff
From Our Partners